Evidence map›Paper›PMID 31218589›Full record

ArticleVirologica Sinica2019

Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.

Zhanqi Dong, Qi Qin, Zhigang Hu, Peng Chen, Liang Huang, Xinling Zhang, Ting Tian, Cheng Lu, Minhui Pan

Open access · bronzeAbstract read
In one paragraph

Article in Virologica Sinica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. CRISPR/Cas12a Mediated Genome Editing EnhancesFrontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Zhanqi DongState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Qi QinState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Zhigang HuState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Peng ChenState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Liang HuangState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Xinling ZhangState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Ting TianState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China.
Cheng LuState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China. lucheng@swu.edu.cn.ORCID http://orcid.org/0000-0002-8577-4288
Minhui PanState Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, 400716, China. pmh047@126.com.ORCID http://orcid.org/0000-0002-2730-4165
Southwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently the developed single guide (sg)RNA-guided clustered regularly interspaced short palindromic repeats/associated protein 9 nuclease (CRISPR/Cas9) technology has opened a new avenue for antiviral therapy. The CRISPR/Cas9 system uniquely allows targeting of multiple genome sites simultaneously. However, there are relatively few applications of CRISPR/Cas9 multigene editing to target insect viruses. To address the need for sustained delivery of a multiplex CRISPR/Cas9-based genome-editing vehicle against insect viruses, we developed a one-vector (pSL1180-Cas9-U6-sgRNA) system that expresses multiple sgRNA and Cas9 protein to excise Bombyx mori nucleopolyhedrovirus (BmNPV) in insect cells. We screened the immediate-early-1 gene (ie-1), the major envelope glycoprotein gene (gp64), and the late expression factor gene (lef-11), and identified multiple sgRNA editing sites through flow cytometry and viral DNA replication analysis. In addition, we constructed a multiplex editing vector (PSL1180-Cas9-sgIE1-sgLEF11-sgGP64, sgMultiple) to efficiently regulate multiplex gene-editing and inhibit BmNPV replication after viral infection. This is the first report of the application of a multiplex CRISPR/Cas9 system to inhibit insect virus replication. This multiplex system can significantly enhance the potential of CRISPR/Cas9-based multiplex genome engineering in insect virus.

Indexed as

CRISPR-Cas SystemsGene EditingGenetic VectorsVirus ReplicationAnimalsBombyxCell LineDNA, ViralGene ExpressionNucleopolyhedrovirusesDNA, ViralAntiviral therapeuticBombyx moriBombyx mori nucleopolyhedrovirus (BmNPV)CRISPR/Cas9Multigene editing

Identifiers

PMID31218589
PMCPMC6687805
OpenAlexW2950980129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.